Anzeige
Mehr »
Login
Samstag, 27.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Geheimtipp: Rasanter Aufstieg, Branchenrevolution und Jahresumsatz von 50 Mio. $
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
Dow Jones News
214 Leser
Artikel bewerten:
(0)

EQS-News: Report on Airopack by Research Dynamics: FY2017 earnings update

Dow Jones received a payment from EQS/DGAP to publish this press release.

EQS Group-News: Research Dynamics / Key word(s): Research Update 
Report on Airopack by Research Dynamics: FY2017 earnings update 
 
2018-04-11 / 08:06 
 
This report is published by Research Dynamics, an independent research 
boutique 
 
*Performance improvements with an eye on future* 
 
*Sales growth backed by strong volume growth* 
 
Airopack reported sales of EUR 21.5 million in 2017, up 90.4% YoY. The 
strong growth in the top-line was driven by higher volumes, which reached 
32.9 million dispensers (4.5x over 2016 sales volume). The strong volume 
growth is a result of the steady ramp-up of the production capacity at the 
Waalwijk facility, where the initial installed annual capacity was 80 
million dispensers. In 2017, the company invested in capacity augmentation 
to harness future growth opportunities. 
 
*Net loss contracts slightly* 
 
Given the ongoing expansion, higher fixed costs took a toll on the 
profitability and Airopack reported a loss of EUR 21.0 million at the EBITDA 
level, albeit lower than in 2016. The increase in operating expenses was 
driven by personnel costs, which grew 40.4% YoY due to a significantly 
higher headcount (166 vs. 123 in 2016). Higher D&A expenditure (due to 
expansion and acquisition of intangibles) and a steep rise in financing 
costs (+50% YoY) led to a net loss of EUR 40.1 million as compared to EUR 
42.3 million in 2016. 
 
*Guidance* 
 
Management plans for a two-phase expansion of the installed production 
capacity to 200 million dispensers by the end of 2018, with the first phase 
expected to increase capacity to 150 million by the end of 1H 2018. 
 
The company expects to reach EBITDA break-even at a run-rate of 100 million 
units in 2H 2018, which is substantiated by the gradual rise in sales 
volumes and significant improvements in EBITDA per million volumes. The 
company has set an ambitious medium-term goal of a run-rate volume of over 
700 million Airopack dispensers annually or around 1.1% of the 66.5 
billion-aerosol market size expected in 2018. 
 
The company succeeded in securing several contracts with new customers 
during 2017, which should result in increased volumes and sales to cover a 
significant portion of fixed production costs. 
 
*Valuation* 
 
We remain optimistic about the growth prospects for Airopack. The company 
has promising plans and aggressive strategies in place to achieve the 
specified targets, along with a global financing partner. We expect Apollo 
to continue to support Airopack in its future endeavours to expand its 
production capacity and in opening new facilities to meet the growing demand 
for Airopack's products. 
 
We believe the company is on track to ramp-up the production capacity from 
initial 80 million units to targeted 200 million by 2018-end. Even though 
the actual production of 40 million units in FY17 is well below our 
previously projected production of 90 million units, due to a delay in the 
initial ramp-up phase of the new production plant, the delay in EBITDA 
breakeven was partially offset by the depreciation of the CHF/EUR exchange 
rate. The company has displayed improved operational efficiencies as evident 
from significant improvement in the gross margin in FY17. Additionally, the 
company's gross margins has benefited from increasing client-base. We adjust 
our model assuming a production of 107 million units, which translates to a 
53.5% capacity utilisation to achieve breakeven EBITDA in 2H18 and for FY18 
on the back of improved gross margins to 61.8%. We foresee EBITDA per 
million volumes to improve further on the back of higher gross profits 
driven by efficient consumption of raw materials. 
 
We anticipate further upside to the stock from current price from synergies 
related to vertical integration of the recently acquired SIPN. Based on a 
Discounted Cash Flow (DCF) approach, we have arrived at a target price of 
CHF 13.3 per share, slightly lower than our previous estimate of CHF 13.5 
per share. We expect the reduction in top-line due to delayed ramp-up of 
production will partially be offset by better than expected operational 
efficiencies. We remain positive on the company considering higher economies 
of scale and increased market share for the company which is less than 1% 
of the total market size of aerosol products (expected to increase at a 
mid-single digit CAGR until 2023 to over 90 billion) across the globe. Given 
the trend towards more planet-friendly technologies in future, we believe 
that Airopack offers a compelling growth story. 
 
Additional features: 
 
Document: http://n.eqs.com/c/fncls.ssp?u=OMWCUVPGWE [1] 
Document title: Research Dynamics_Airopack_FY17 earnings results 
 
End of Corporate News 
673283 2018-04-11 
 
 
1: http://public-cockpit.eqs.com/cgi-bin/fncls.ssp?fn=redirect&url=f3011cc5ad7e362e0d40adb677f41dcd&application_id=673283&site_id=vwd&application_name=news 
 

(END) Dow Jones Newswires

April 11, 2018 02:06 ET (06:06 GMT)

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2018 Dow Jones News
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.